ST
RPRX

Spot Trading’s Repros Therapeutics Inc. RPRX Stock Holding History

Spot Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-150
Closed – – 4575
2015
Q4 		$0 Buy
+150
New +$481 ﹤0.01% 4563
2015
Q1 		– Sell
-103,020
Closed -$1.03M – 4862
2014
Q4 		$1.03M Buy
103,020
+58,455
+131% +$498K 0.01% 1862
2014
Q3 		$441K Buy
+44,565
New +$660K ﹤0.01% 2638
2013
Q4 		– Sell
-71,360
Closed -$1.35M – 4755
2013
Q3 		$1.91M Buy
+71,360
New +$1.53M 0.01% 1409

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Spot Trading's RPRX Position: Q1 2016 in Review

Spot Trading sold out of Repros Therapeutics Inc. (RPRX) in Q1 2016, closing a stake of 150 shares.

Spot Trading first reported a position in RPRX in Q3 2013 and held it in 4 quarters. The position peaked at $1.91M in Q3 2013. 53 funds tracked by Wall St. Rank hold RPRX as of Q1 2016.

  • Spot Trading reported no remaining Repros Therapeutics Inc. position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 150 Repros Therapeutics Inc. shares in Q1 2016.
  • Spot Trading first reported a position in Repros Therapeutics Inc. in Q3 2013 and held it in 4 quarters.
  • Spot Trading's Repros Therapeutics Inc. position peaked at $1.91M in Q3 2013.
  • 53 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.